GENEROS BIOPHARMA LTD has a total of 19 patent applications. Its first patent ever was published in 2018. It filed its patents most often in WIPO (World Intellectual Property Organization), China and Australia. Its main competitors in its focus markets pharmaceuticals, biotechnology and foods and drinks are STAIDSON BEIJING BIOPHARMACEUTICALS CO LTD, TRANSGENE and WEINER DAVID B.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 4 | |
#2 | China | 3 | |
#3 | Australia | 2 | |
#4 | Canada | 2 | |
#5 | EPO (European Patent Office) | 2 | |
#6 | Republic of Korea | 2 | |
#7 | Taiwan | 2 | |
#8 | United States | 2 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Foods and drinks | |
#4 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Microorganisms | |
#4 | Enzymes | |
#5 | Peptides | |
#6 | Heterocyclic compounds |
# | Name | Total Patents |
---|---|---|
#1 | Fu Xin-Yuan | 15 |
#2 | Liu Xinyu | 6 |
#3 | Zhou Yi | 6 |
#4 | Lufei Chengchen | 4 |
#5 | Lu Cenbin | 3 |
#6 | Fu Xin Yuan | 2 |
#7 | Fu Xinyuan | 2 |
#8 | Lu-Fei Chengchen | 2 |
Publication | Filing date | Title |
---|---|---|
WO2020221347A1 | Compound for treating autoimmune skin diseases caused by inflammation, and use thereof | |
WO2020216378A1 | Heterocyclic compound, application thereof, and composition containing same | |
CN111848598A | Heterocyclic ring-containing compound, application thereof and composition containing heterocyclic ring-containing compound | |
WO2020216335A1 | Use of compound in preparation of drug for treating atherosclerosis | |
WO2020207344A1 | Pharmaceutical combination of pimozide and methotrexate and use thereof | |
EP3628008A1 | Compositions and methods for treating alzheimer's disease | |
US2020306235A1 | Compositions and methods for treating rheumatoid arthritis |